BD (Becton, Dickinson and Company), a leading global medical technology firm, has become the first in the medtech industry to earn a diamond-level rating across all seven supply chain resilience domains of the Healthcare Industry Resilience Collaborative’s (HIRC) Resiliency Badging Programme. The recognition covers BD’s urology and critical care (UCC) and surgery business units.

“Achieving HIRC’s Diamond Status Resiliency Badge recognizes BD’s commitment to building a resilient end-to-end supply chain across multiple product categories and our relentless pursuit of process excellence and continuous improvement,” said Tony Ezell, executive vice president and president of the Americas region at BD. “Hundreds of millions of patients depend on BD, and this recognition is a testament to the work our team does every day to ensure products arrive on time and in the right quantities.”

HIRC, a non-profit healthcare supply chain trade association founded in 2019, focuses on improving transparency, resilience, and operational efficiency. Its Resiliency Badge Programme involves a rigorous audit to assess domains including demand planning, supplier management, inventory management, logistics, supply chain visibility, risk management and contingency planning, and operational health. BD achieved top-tier performance in each of these areas for its Surgery and UCC businesses.

The company was first recognized by HIRC in 2023 with the Transparency Partner Badge. This latest diamond-level distinction underscores BD’s continued investment in supply chain and manufacturing enhancements, such as expanding safety stock, increasing production capacity for critical products, and improving order management systems to give customers real-time supply and delivery insights.

BD, one of the world’s largest medical technology companies, is committed to advancing healthcare through innovative technologies, services, and solutions that improve medical discovery, diagnostics, and care delivery.